Literature DB >> 27308536

Hepatic cancer stem cells may arise from adult ductal progenitors.

Kostas C Nikolaou1, Iannis Talianidis1.   

Abstract

Cancer stem cells (CSCs) are defined as cells within tumors that can self-renew and differentiate into heterogeneous lineages of cancerous cells. The origin of CSCs is not well understood. Recent evidence suggests that CSCs in hepatocellular carcinoma could be generated via oncogenic transformation and partial differentiation of adult hepatic ductal progenitor cells.

Entities:  

Keywords:  PR-SET7; cancer stem cells; ductal progenitors; hepatocellular carcinoma

Year:  2015        PMID: 27308536      PMCID: PMC4845172          DOI: 10.1080/23723556.2015.1021946

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  10 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Hashem B El-Serag
Journal:  N Engl J Med       Date:  2011-09-22       Impact factor: 91.245

2.  Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.

Authors:  Guobin He; Debanjan Dhar; Hayato Nakagawa; Joan Font-Burgada; Hisanobu Ogata; Yuhong Jiang; Shabnam Shalapour; Ekihiro Seki; Shawn E Yost; Kristen Jepsen; Kelly A Frazer; Olivier Harismendy; Maria Hatziapostolou; Dimitrios Iliopoulos; Atsushi Suetsugu; Robert M Hoffman; Ryosuke Tateishi; Kazuhiko Koike; Michael Karin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

3.  Robust cellular reprogramming occurs spontaneously during liver regeneration.

Authors:  Kilangsungla Yanger; Yiwei Zong; Lara R Maggs; Suzanne N Shapira; Ravi Maddipati; Nicole M Aiello; Swan N Thung; Rebecca G Wells; Linda E Greenbaum; Ben Z Stanger
Journal:  Genes Dev       Date:  2013-03-21       Impact factor: 11.361

Review 4.  Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming.

Authors:  Atsushi Miyajima; Minoru Tanaka; Tohru Itoh
Journal:  Cell Stem Cell       Date:  2014-05-01       Impact factor: 24.633

Review 5.  Cancer stem cells: current status and evolving complexities.

Authors:  Jane E Visvader; Geoffrey J Lindeman
Journal:  Cell Stem Cell       Date:  2012-06-14       Impact factor: 24.633

Review 6.  Molecular pathways: the complex roles of inflammation pathways in the development and treatment of liver cancer.

Authors:  Kostas Nikolaou; Michalis Sarris; Iannis Talianidis
Journal:  Clin Cancer Res       Date:  2013-04-02       Impact factor: 12.531

7.  Adult hepatocytes are generated by self-duplication rather than stem cell differentiation.

Authors:  Kilangsungla Yanger; David Knigin; Yiwei Zong; Lara Maggs; Guoqiang Gu; Haruhiko Akiyama; Eli Pikarsky; Ben Z Stanger
Journal:  Cell Stem Cell       Date:  2014-08-14       Impact factor: 24.633

8.  Cholangiocarcinomas can originate from hepatocytes in mice.

Authors:  Biao Fan; Yann Malato; Diego F Calvisi; Syed Naqvi; Nataliya Razumilava; Silvia Ribback; Gregory J Gores; Frank Dombrowski; Matthias Evert; Xin Chen; Holger Willenbring
Journal:  J Clin Invest       Date:  2012-07-17       Impact factor: 14.808

9.  Evidence against a stem cell origin of new hepatocytes in a common mouse model of chronic liver injury.

Authors:  Johanna R Schaub; Yann Malato; Coralie Gormond; Holger Willenbring
Journal:  Cell Rep       Date:  2014-08-14       Impact factor: 9.423

10.  Spontaneous development of hepatocellular carcinoma with cancer stem cell properties in PR-SET7-deficient livers.

Authors:  Kostas C Nikolaou; Panagiotis Moulos; George Chalepakis; Pantelis Hatzis; Hisanobu Oda; Danny Reinberg; Iannis Talianidis
Journal:  EMBO J       Date:  2014-12-16       Impact factor: 11.598

  10 in total
  1 in total

1.  Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM).

Authors:  Rong Wang; Laixiu Yang; Shen Li; Dongmei Ye; Lihong Yang; Qingyan Liu; Zibo Zhao; Qing Cai; Junzhen Tan; Xiuli Li
Journal:  Med Sci Monit       Date:  2018-01-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.